STOCK MARKET BSE NSE

SII urges Mandaviya to reduce gap between 2nd, precaution dose of Covishield from 9 to 3 months

This will help to control unpredictable and fast spread of various strains of COVID-19, claimed the Pune-based firm.

Published: 04th February 2022 12:26 AM  |   Last Updated: 04th February 2022 12:26 AM   |  A+A-

Covishield

A health worker holds up a Covishield vial. (File Photo | EPS)

By PTI

NEW DELHI: Serum Institute has urged Union Health Minister Mansukh Mandaviya to consider reducing the gap between the second and the precaution dose of Covishield from current nine months to three, in line with Centre's revised guidelines for officials on election duty, official sources said on Thursday.

The Pune-based firm also requested the minister to allow it to administer Covishield's precaution dose for all individuals aged above 18 years.

In a letter to Mandaviya, Prakash Kumar Singh, director, Government and Regulatory Affairs at SII, is learnt to stated that the third dose of COVID-19 vaccine is being administered within 6 months of the second dose in various countries and this schedule is giving very good results to control the infection, an official source said.

Singh also mentioned that private companies, educational institutions, social organisations, central government organisations as well as public undertaking companies etc are continuously requesting the firm for the third dose of Covishield for their staff members and families.

He referred to Union Health Ministry's letter dated January 21 according to which the precaution dose can be administered 3 months after the second dose of the vaccine was given to officials and staff deployed on election duty in the poll-bound states of Goa, Manipur, Punjab, Uttarakhand and Uttar Pradesh.

For this, necessary changes have been made on the CoWIN portal to facilitate early administration of the precaution dose.

Till January 28, more than one crore people were administered the third dose of the COVID-19 vaccine out of which more than 90 lakh doses were of Covishield.

"In view of the above facts, we request for your kind intervention and consideration on our following submissions: The administration of third dose of our Covishield vaccine should be allowed for all individuals above the age of 18 years."

"The gap between second and third dose to be reduced and the administration of third dose of Covishield vaccine to be allowed after the completion of 3 months in line with revised guidelines of GoI for the officials and staff deployed on election duty," the official source quoted Singh as having said in the letter.

"Sir, it is need of the hour and in the interest of public at large. This will help to control unpredictable and fast spread of various strains of COVID-19 which is disrupting economy and social stability of our country," Singh said in the letter.



Comments

Disclaimer : We respect your thoughts and views! But we need to be judicious while moderating your comments. All the comments will be moderated by the newindianexpress.com editorial. Abstain from posting comments that are obscene, defamatory or inflammatory, and do not indulge in personal attacks. Try to avoid outside hyperlinks inside the comment. Help us delete comments that do not follow these guidelines.

The views expressed in comments published on newindianexpress.com are those of the comment writers alone. They do not represent the views or opinions of newindianexpress.com or its staff, nor do they represent the views or opinions of The New Indian Express Group, or any entity of, or affiliated with, The New Indian Express Group. newindianexpress.com reserves the right to take any or all comments down at any time.

flipboard facebook twitter whatsapp